✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyIndustry Why This Matters Clinicians treating obesity and epilepsy patients should monitor developments from endocannabinoid-targeted...
Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyPolicyPediatricsCBD Why This Matters Clinicians treating children with drug-resistant epilepsy need awareness that medical cannabis...
Study Shows Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia …
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyAgingSafety Why This Matters Clinical RelevanceClinicians can use this evidence to counsel older patients that...
Study: Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia Risk in … – NORML
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchNeurologyAgingSafety Why This Matters Clinicians counseling older adults about cannabis safety can now reference prospective...
Omagh biotech start-up in funding boost for research into obesity and epilepsy
✦ New CED Clinical Relevance #62 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyIndustry Why This Matters Clinicians treating obesity and epilepsy patients need to monitor this endocannabinoid...
Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyPolicyPediatricsCBD Why This Matters Clinicians treating children with drug-resistant epilepsy need to understand the access...
Study: Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia Risk in … – NORML
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. NeurologyResearchAgingSafety Why This Matters This study provides clinicians with evidence to reassure older adult patients...
Study Shows Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia …
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchNeurologyAgingSafety Why This Matters Clinicians can now counsel older patients that lifetime cannabis use alone...
The Wait is Over: Medical Cannabis set to roll out in April | WHNT.com
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyPainMental Health Clinical Summary Alabama’s medical cannabis program is moving forward after a lengthy regulatory...
GLP-1 medications get at the heart of addiction, study finds
✦ New CED Clinical Relevance #62 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthSafetyNeurology Why This Matters GLP-1 medications show promise in reducing cannabis use disorder alongside...